 |
|
|
|
 |
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
|
|
CEDARA SOFTWARE ANNOUNCES INTRODUCTION OF C4 ENABLED
DIGITAL MAMMOGRAPHY APPLICATION
I-ReadMammo™ can be plugged into all C4™ ( Cedara Clinical Control Center)
enabled solutions
Toronto, ON, September 6, 2007 – Cedara Software, a Merge Healthcare company (NASDAQ: MRGE;TSX: MRG), and a leading medical imaging software and services provider, announced the introduction of a C4 enabled I-ReadMammo, creating a plug-in version of its successful digital mammography solution. C4 enabled I-ReadMammo is designed for modular integration into any C4 enabled imaging solution, such as a Picture Archiving and Communications System (PACS). Cedara also reported that several imaging equipment vendors already are integrating this new C4 enabled version of I-ReadMammo into their PACS solutions.
Cedara’s recently introduced C4 platform is an integration framework that facilitates plug-in integration of clinical applications with minimal changes to the host (e.g. PACS) software product. A C4 enabled host integrated with one or more C4 enabled clinical applications provides an integrated desktop environment with procedure-centric workflow. The C4 platform supports integration with imaging companies’ PACS, Radiology Information Systems (RIS) and Electronic Medical Record (EMR) systems. The term “C4 enabled” refers both to the C4 host – for example, a PACS workstation – and to the clinical application that runs on the host, such as a 3D angiography visualization tool or a planning package for orthopaedic procedures. C4 provides a standard interface for all bi-directional information between the C4 enabled host and clinical application plug-in, creating a tightly integrated solution that is designed to maximize productivity.
“C4 enabled I-ReadMammo represents another opportunity for clinicians to provide the benefits of digital mammography for their patients,” said Cedara Software president Loris Sartor. “Now, obtaining these benefits can be as simple as plugging the software application into the C4 enabled host manufactured by the PACS, RIS or EMR company.”
Cedara Software’s popular I-ReadMammo application was specifically designed to address the entire breast imaging workflow. Both standalone and C4 enabled versions of I-ReadMammo are multi-modality, vendor-neutral digital mammography workstation solutions, enabling healthcare organizations on a single workstation to display and read images from different vendors and different acquisition devices (digital mammography, ultrasound, MR, CR).
Another Cedara C4 enabled clinical application is Cedara OrthoWorks ProPlanner™. Under development are C4 enabled PET/CT*, for advanced radiology procedures, and Cedara B-CAD*, to assist in breast ultrasound analysis. New third-party clinical packages from Biotronics3D also are under development for 3D virtual colonoscopy, 3D angiography and 3D general diagnostics.
*Note: C4 enabled PET/CT and C4 enabled B-CAD are works-in-progress.
# # #
Cedara Software is a Merge Healthcare company focused on the development of customized software solutions and development tools for the medical imaging OEM market. Cedara’s solutions enable OEM companies to accelerate their time-to-market, reduce development costs and access new streams of revenue. Cedara’s software is deployed in hospitals and clinics worldwide and is licensed by many of the world's leading medical device and healthcare information technology companies. Cedara’s technologies and engineering services span all the major digital imaging modalities and a wide variety of clinical specialties including radiology, orthopaedics, women’s health, oncology, cardiac imaging, clinical trials, imaging for the veterinarian market and more. For additional information, visit our website at www.cedara.com .
Merge Healthcare is a leading medical imaging software and services company. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.mergehealthcare.com.
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
